Inflammation, specifically due to cytokines and chemokines produced by FFA and gut-derived LPS activation of TLR4 signaling, leads to systemic glucose intolerance by impairing insulin signaling in target tissues including adipose and liver. The gene discussed is TLR4; the disease is Glucose intolerance.